IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Clinical trials for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) explained in plain language.
Never miss a new study
Get alerted when new IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) trials appear
Sign up with your email to follow new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug showdown: which Beta-Blocker protects ICD patients best?
Disease control Recruiting nowThis study compares two common heart failure medications, carvedilol and metoprolol succinate, in 2,000 adults who have an implantable defibrillator (ICD). Participants currently taking metoprolol will be randomly assigned to either stay on it or switch to carvedilol. The goal is…
Matched conditions: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New eHealth tool aims to ease anxiety for ICD patients
Knowledge-focused Recruiting nowThis study is creating and testing an online resource called CHOICE-ICD for people who have an implantable cardioverter defibrillator (ICD). The tool provides easy-to-understand information, games, and videos to help patients and their families learn about the device and manage c…
Matched conditions: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Phase: NA • Sponsor: University of Ulster • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC